Direct-To-Consumer Healthcare And Its Expanding Role In The Australian Healthcare System

January 2026 in “ Internal Medicine Journal ”

Jingwen Lu, Deshan F. Sebaratnam

Studysummary This study emphasizes the need for a formal evaluation of direct-to-consumer telemedicine services in Australia to ensure safety, privacy, and ethical standards while maintaining high-quality healthcare.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Direct-To-Consumer Androgenetic Alopecia Treatments: A Cost Comparison With Traditional Pharmacies

September 2024 in “Journal of the American Academy of Dermatology”

research Patient-Reported Outcomes and Safety of Direct-to-Consumer Teledermatology for Finasteride in Male Androgenetic Alopecia

January 2023 in “DIGITAL HEALTH”

This study found that users of a German direct-to-consumer teledermatology platform for finasteride reported improvements in hair appearance and self-esteem, though 12% experienced treatment-related adverse events.

Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment

research Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment

24 citations , September 2020 in “Dermatology and therapy”

This study found that low-dose oral minoxidil 5 mg daily significantly increased hair growth in men with androgenetic alopecia over 24 weeks, with increased hair count and vertex area improvement, though most experienced hypertrichosis and some had pedal edema.